US2017216486A1PendingUtilityA1

System and Method for Treating a Wound

Assignee: GENADYNE BIOTECHNOLOGIES INCPriority: Jan 29, 2016Filed: Jan 30, 2017Published: Aug 3, 2017
Est. expiryJan 29, 2036(~9.5 yrs left)· nominal 20-yr term from priority
A61L 26/0066A61L 2300/104A61L 2300/406A61L 26/0057A61L 26/0004A61L 15/40A61L 2300/404A61L 15/28
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

In at least one embodiment there is a wound application comprising at least one film applied over a wound comprising at least 1% green tea, and at least 0.01% sugar, wherein said film comprises a polymeric film comprising united chains and monomeric glucose points. In at least one other embodiment there is a wound application comprising a solution comprising at least trace amounts of colloidal silver, at least trace amounts of sodium chloride, at least trace amounts of dextrose; and water, wherein the colloidal silver, the sodium chloride and the dextrose are dissolved in water. In at least one other embodiment there is an application for treating a wound comprising both a solution comprising at least trace amounts of colloidal silver and a film comprising at least trace amounts of green tea applied over the solution on top of a wound.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A wound application comprising:
 at least one film applied over a wound comprising:   at least 1% green tea; and   at least 0.01% sugar, wherein said film comprises a polymeric film comprising united chains and monomeric glucose points.   
     
     
         2 . The wound application as in  claim 1 , wherein said film further comprises at least 1% sugar. 
     
     
         3 . The wound application as in  claim 1 , wherein said film further comprises at least trace amounts of  Gluconacetobacter xyliunus.    
     
     
         4 . The wound application as in  claim 1 , wherein said film further comprises at least trace amounts of propolis. 
     
     
         5 . The wound application as in  claim 1 , further comprising:
 a solution comprising at least 0.003% colloidal silver, wherein said solution comprising at least 0.003% colloidal silver is applied to the wound before applying said film.   
     
     
         6 . The wound application as in  claim 1 , wherein said solution of at least 0.003% colloidal silver is applied in a form of a spray. 
     
     
         7 . The wound application as in  claim 1 , wherein said solution of at least 0.003% colloidal silver is applied in a form of a gel. 
     
     
         8 . The wound application as in  claim 1 , wherein said solution of at least 0.003% colloidal silver further comprises at least 1% dextrose. 
     
     
         9 . The wound application as in  claim 1 , wherein said solution of at least 0.003% colloidal silver further comprises 0.01% sodium chloride. 
     
     
         10 . The wound application as in  claim 1 , wherein said solution of at least 0.03% colloidal silver further comprises water. 
     
     
         11 . A wound application comprising:
 a solution comprising:   at least trace amounts of colloidal silver;   at least trace amounts of sodium chloride;   at least trace amounts of dextrose; and   water, wherein the colloidal silver, the sodium chloride and the dextrose are dissolved in water.   
     
     
         12 . The wound application as in  claim 11 , wherein the solution comprises:
 at least 0.003% colloidal silver;   at least 0.01% sodium chloride;   at least 5% dextrose; and   water.   
     
     
         13 . The wound application as in  claim 11 , wherein the solution comprises:
 at least 0.004% colloidal silver.   
     
     
         14 . The wound application as in  claim 11 , wherein the solution comprises:
 at least 0.005% colloidal silver.   
     
     
         15 . The wound application as in  claim 11 , wherein the solution is dispersed inside of a hydrogel. 
     
     
         16 . The wound application as in  claim 11 , further comprising a film, wherein the solution is applied first and the film is applied over the solution on the wound. 
     
     
         17 . The wound application as in  claim 16 , wherein the film comprises at least trace amounts of green tea. 
     
     
         18 . The wound application as in  claim 17 , wherein the film comprises at least trace amounts of sugar. 
     
     
         19 . The wound application as in  claim 18 , wherein the film is a membrane formed by a hemicellulose polymeric film having structured united chains and monomeric glucose points. 
     
     
         20 . The wound application as in  claim 19 , wherein said film further comprises propolis.

Join the waitlist — get patent alerts

Track US2017216486A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.